AGP Picks
View all

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on June 19, 2026

AHA Stroke Alert Podcast Features HeartLung.AI Research on AI-Predicted Atrial Fibrillation and Stroke
Cypress Lake Recovery Launches Wellbriety Trail, a One-of-a-Kind Healing Path Rooted in First American Tradition
PitPat Launches “Run for the Cup” Global Fitness Challenge with $100 Reward Pool for 10-Minute Workout
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026   
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
Boston Dental Named The Best Dentist in Boston
BizCloud Experts Launches Catalyst Learning Center — A Complete Training and Certification Hub for the Modern Enterprise
More Adults Are Turning to Better Sleep Hygiene in a Phone-Free Bedtime Environment
Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities' first inpatient behavioral health treatment and recovery facility
FDA Approves Labeled Strength Update of TWIRLA® (levonorgestrel/ethinyl estradiol) Birth Control Patch
Protein Labeling Market to Reach New Heights by 2031, Driven by Surge in Biomedical Research Funding
Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam
As U.S. Birth Rates Hit Record Lows, Pozitivf Fertility Makes a Public Commitment to Affordable IVF
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.